Has Shannon Foster, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,691 in general payments to Shannon Foster, MD across 432 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shannon Foster, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shannon Foster, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shannon Foster, MD

Dermatology · Missoula, MTNPI 1356549406

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,776 of the $10,691 with a category attached, or 82.1%. It is spread thinly across 23 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,691in general payments, 2019–2025

Across 432 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
E.r. Squibb & Sons, L.L.C.$2K
AbbVie$2K
Lilly USA, LLC$842
UCB, Inc.$517
Amgen$495
plus $2K from 17 others

What the payments were for

Consulting fees$1,80017%
Food & beverage$8,77682%
Education$1141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	69	$2,253
E.r. Squibb & Sons, L.L.C.	21	$2,233
AbbVie	149	$1,928
Lilly USA, LLC	43	$842
UCB, Inc.	22	$517
Amgen	22	$495
Regeneron Healthcare Solutions, Inc.	19	$487
Sanofi	20	$427
Johnson & Johnson	17	$382
Prugen, Inc. Pharmaceuticals	5	$258
Boehringer Ingelheim	5	$223
Incyte Corporation	9	$197
Pfizer	10	$134
Sun Pharmaceutical Industries Inc.	8	$103
Galderma Laboratories, L.p.	3	$45
Dermavant Sciences, Inc.	2	$39
Blueprint Medicines Corporation	1	$29
Organogenesis Inc.	2	$25
Kyowa Kirin, Inc.	1	$19
LEO Pharma Inc.	1	$17
Sanofi-aventis U.S. LLC	1	$15
Mimedx Group, Inc.	1	$14
Organon	1	$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COSENTYX$213
SPEVIGO$125
Otezla$103

How this compares

$10,691 in reported general payments places this provider in the 95th percentile of 46 dermatology providers in Montana.

See all dermatology providers in Montana →

Medicare billing

Part B allowed, 2024

$312,531

Medicare patients

1,338

Services billed

5,442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	79	$290,880
Dupixent SyringeDupilumab	51	$194,628
Humira(Cf) PenAdalimumab	13	$166,844
Bexarotene	12	$12,434
Clobetasol Propionate	101	$4,213
Tacrolimus	34	$2,554
Fluorouracil	34	$2,522
Doxycycline Hyclate	77	$2,248
Metronidazole	31	$2,229
Acitretin	14	$2,023
Triamcinolone Acetonide	189	$1,636
Ketoconazole	95	$1,421
Tretinoin	15	$1,087
Doxycycline Monohydrate	36	$1,066
Mometasone Furoate	45	$1,031

Paid to pharmacies, not to this prescriber.

Other dermatology in Missoula

Neil SwansonMissoula$148K
Jessica SemplerMissoula$7K
Troy DavisMissoula$6K
Andrew TegederMissoula$3K
Erika HagstromMissoula$2K
Jacob IndaMissoula$2K
Allyson YelichMissoula$1K
Kevin McMullenMissoula$925
Charlotte KutschMissoula$243
Leslie StappGreat Falls$58K

See the full list for Montana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →